Positions 101–125 of 130.
anyone else notice triple agonist kicking in around week 65. Numbers below. Ask me the boring questions, they are the useful ones. Kept a log specifically because there…
glucagon: what the trials say vs what this community says, and I am aware this is a minority view on this board. Where the evidence actually stands, since every thread…
split one vial across Janoshik and Medutest — 95.1% and 99.3%. I will put the method line and the batch identifier up front because that is what makes this checkable.…
Something I keep coming back to: reading triple agonist threads from 2024 and half of it aged badly. The phase 2 readout ran to 48 weeks in a few hundred participants…
Vendor-level purity averages over time, built from independent results rather than vendor claims. Transparent methodology, open dataset.
Browse resultsThinking out loud about this: stalled for 7 weeks at 10mg and I refuse to panic this time. 7 weeks and 10mg — those are the numbers, and they are the ones I am willing…
what changed for me between month 8 and month 16, and I want the answer with the reasoning attached rather than just the conclusion. Sent a vial to Medutest out of…
Genuine question, and the title is the question: someone explain phase 2 to me like I have not read a paper in years. Stopped at a low step because there was no reason…
am I the only one who found glucagon harder than the injections. I am not trying to be the "source?" guy. I would just like a source. Increases in heart rate have been…
26 weeks, 5kg, and dose escalation was the hard part. Same spreadsheet I have been keeping since the start, nothing retrofitted. Figures up front so nobody has to dig:…
The title is the whole question — what would you tell week-1 you about dose escalation — but here is why I am asking. It is a triple agonist at the GLP-1, GIP and…
Title says it — 2th independent test on BCH — 97.8% on a claimed 97.5%, and the trend is the interesting part — so here is the boring supporting detail that makes it…
switched from 10mg to 15mg and nausea got better, not worse, which sounds obvious until you try to state the evidence for it. Numbers, in the order they matter: 10mg…
retatrutide: what the trials say vs what this community says. I have gone back and forth on this for months. Where the evidence actually stands, since every thread here…
Genuine question, and the title is the question: help me understand dose escalation, I have read the wiki twice. The constipation profile felt different rather than…
is it normal to get sulphur burps at week 24. Full detail below, and I have tried to keep the editorialising out of it. The phase 2 readout ran to 48 weeks in a few…
Reference standards, analytical reagents and system-suitability material. If you are running your own method, start with a known.
Reference standardsstalled for 17 weeks at 2.5mg and I refuse to panic this time. I have gone back and forth on this for months. 17 weeks and 2.5mg — those are the numbers, and they are…
small win: triple agonist stopped being a problem at week 65, and the part I actually want to talk about is at the bottom. The early fullness profile felt different…
Check-in as promised in the title: 10 months in and dose escalation is still the thing I get wrong. 10 months. Those are measured, not estimated, and not rounded up in…
week 19 check-in — 9kg down, early fullness manageable, one thing confusing me, logged the same way every week so the comparison is at least internally fair. The…
45 weeks on 10mg, full numbers, ask me anything boring, and the part I actually want to talk about is at the bottom. Pulling the figures out of the title: 45 weeks and…
unpopular opinion: most of what gets said here about glucagon is guesswork, and I am aware this is a minority view on this board. Where the evidence actually stands,…
anyone else notice dose escalation kicking in around week 37. Posting the boring middle of the process, because the internet is full of the start and the end and…
Short public-service post: TRIUMPH is not what most of this community thinks it is. Went up slowly, deliberately, because everything on this board says the escalation…
Putting this to the board: proposal — a flair for glucagon posts. What the glucagon arm is doing, as best anyone can say from public data. GLP-1 and GIP agonism cover…
Trying to get a straight answer on this: triple agonist — what am I missing here. Watched heart rate on a wearable across twelve weeks because the threads said to. It…
Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.
Certified reference materials for peptide identity and purity work.
sigmaaldrich.comSeveral compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.
Reference